NCT01189032View on ClinicalTrials.gov

Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

PHASE2CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

Not specified

Primary Completion Date

July 31, 2006

Conditions
Dry Eye
Interventions
DRUG

DE-089 ophthalmic solution

DRUG

DE-089 ophthalmic solution

DRUG

Placebo ophthalmic solution

Trial Locations (1)

Unknown

Santen study sites, Osaka

All Listed Sponsors
lead

Santen Pharmaceutical Co., Ltd.

INDUSTRY

NCT01189032 - Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye | Biotech Hunter | Biotech Hunter